1,183 results on '"Feliu, J."'
Search Results
202. La dilataci�n neum�tica en 117 casos de achalasia esofagica
203. Hernias de hiato e insuficiencia coronaria
204. Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?
205. Incidence of Chemotherapy-Induced Nausea and Vomiting with Moderately Emetogenic Chemotherapy: Advice Study
206. Finding Molecular Subgroups of Worse Prognosis Studying the Microenvironment of Gastro-Entero-Pancreatic Neuroendocrine Tumours (Gep-Net).
207. A Validation of Current Prognostic Scores in Metastatic Colorectal Cancer (Mcrc) and a New Prognostic Score (A Gemcad Study)
208. Early-Onset Hypothyroidism and Survival in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Sunitinib: Updated Overall Survival Data
209. First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
210. Comunidades Imaginadas: Nacionalismo Banal en los Locutorios de Barcelona
211. Differences between lactate concentration of samples from ear lobe and the finger tip
212. 540P - Prospective evaluation of BRAF, PI3K and PTEN as predictive and prognostic biomarkers in first-line advanced KRAS wild-type colorectal cancer treated with FOLFOX or FOLFIRI plus bi-weekly cetuximab. GEMCAD 10-02
213. 499P - PULSE, a phase 2 study of mFOLFOX6-panitumumab (P) with biomarker stratification as first-line chemotherapy (CT), in patients (pts) with KRAS (exon 2) metastatic colorectal cancer (mCRC). A GEMCAD 09-03 study
214. The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group
215. Fundamental aspects of HCOOH oxidation at platinum single crystal surfaces with basal orientations and modified by irreversibly adsorbed adatoms
216. Redox transformations of adsorbed NO molecules on a Pt(100) electrode
217. La logistique urbaine à l’épreuve du facteur 4
218. Study of the free radical polymerization of MMA by adiabatic calorimetry
219. Influence of scrap rubber addition to Portland I concrete composites: Destructive and non-destructive testing
220. Pharmacogenetic Predictors of Severe Chronic Peripheral Neuropathy in Stage II-III Colon Cancer (CC) Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy (CT). A Gemcad Study
221. Single Institution Phase I Trial of the Novel Compound First-In-Class PDM08 in Refractory Solid Tumors (NCT01380249)
222. Internet Use by Cancer Patients and Their Relatives: an Useful Information Tool Ir Our Country or a Confusion Element? : Final Results of Our Study
223. Cutaneous relapse of an ampullary carcinoma: an unusual presentation
224. Analysis of the Concordance in the EGFR Pathway Status Between Primary Tumors and Related Metastases of Colorectal Cancer Patients:Implications for Cancer Therapy
225. Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma
226. Prediction of Warfarin Dose Reductions in Puerto Rican Patients, Based on Combinatorial CYP2C9 and VKORC1 Genotypes
227. Mechanistic changes observed in heavy water for nitrate reduction reaction on palladium-modified Pt(hkl) electrodes
228. A kinetic study of the polymerization of MMA
229. The present and future of gene profiling in breast cancer
230. A phase I dose-finding study of sorafenib (S) in combination with gemcitabine (G) and radiotherapy (RT) in patients (pts) with unresectable pancreatic carcinoma (UPC): A GEMCAD study.
231. 292 MDS patients treated with 5-AZA in La Rioja (Spain): Results and application of the prognostic score proposed by Itzykson et al.
232. Study on the deterioration of verbal memory in colon cancer patients after receiving adjuvant chemotherapy.
233. Shape dependent electrocatalysis
234. Formic acid oxidation
235. Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
236. Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
237. ChemInform Abstract: Oxidation of Formic Acid on Pt(100) Electrodes Modified by Irreversibly Adsorbed Tellurium.
238. Analysis of EGFR pathway mediators in KRAS wild-type primary tumors is not representative of their status in related metastases.
239. Effect of the quality of the methodology on the relationship between progression-free survival (PFS) and overall survival (OS) in advanced colorectal cancer clinical trials.
240. A combined strategy of serial analysis of gene expression (SAGE) and quantitative PCR (qPCR) to identify four genes that predict outcome in non-small cell lung cancer patients.
241. Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
242. Large lymph node size harvested as prognostic factor in gastric cancer?
243. Phase I study of UFT plus leucovorin in advanced colorectal cancer: a double modulation proposal
244. 2103 Accuracy of integrated PET-CT for mediastinal lymph node metastases in non-small cell lung cancer
245. Survival prediction in terminally ill cancer patients: Description and validation of a new predictive score
246. Phase II study to evaluate the efficacy of capecitabine combined with bevacizumab as first-line treatment in elderly patients with advanced or metastatic colorectal adenocarcinoma
247. Is hepcidin involved in anemia of advanced non-small cell lung carcinoma (NSCLC) patients treated with platin-based chemotherapy? An exploratory study
248. Immunohistochemical analysis of tumor regression grade for rectal cancer after neoadjuvant chemoradiotherapy
249. Screening candidate targets by SAGE evaluation of rectal cancer transcriptome after chemoradiotherapy: Association of trefoil factor-family 3 (TFF3) expression with patients prognosis
250. In Situ Surface Characterization and Oxygen Reduction Reaction on Shape-Controlled Gold Nanoparticles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.